Phase 2 Lung Cancer (Non-Small Cell) Clinical Trials
9 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–9 of 9 trials
Recruiting
Phase 2
A Phase II Study of SKB571 in Patients With Lung Cancer
Lung Cancer (Non-Small Cell)
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.295 enrolled2 locationsNCT07230405
Recruiting
Phase 2
IBI351 Plus Cetuximab β in Untreated Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
Lung Cancer (Non-Small Cell)
Guangdong Association of Clinical Trials48 enrolled7 locationsNCT07198841
Recruiting
Phase 1Phase 2
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
Breast CancerProstate Cancer Castration-resistant Prostate CancerColo-rectal Cancer+2 more
MBrace Therapeutics150 enrolled7 locationsNCT07145255
Recruiting
Phase 1Phase 2
Evaluation of Programmed Death Ligand 1 (PDL1) Response to Treatment in Extracellular Vesicles (EVs), Patient-derived Organoid (PDOs)s and Immune-marker Positron Emission Tomography (PET) Scanning in Non-small Cell Lung Cancer (NSCLC)
Lung Cancer (Non-Small Cell)
GlaxoSmithKline40 enrolled1 locationNCT06405230
Recruiting
Phase 1Phase 2
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
Advanced CancerLung Cancer (Non-Small Cell)Solid Tumor, Adult+2 more
Krystal Biotech, Inc.250 enrolled14 locationsNCT06228326
Recruiting
Phase 2
Perioperative Tislelizumab for Resectable II-IIIB(N2) KRAS-mutated Nonsquamous Non-small Cell Lung Cancer
Lung Cancer (Non-Small Cell)
Shanghai Chest Hospital32 enrolled1 locationNCT06659042
Recruiting
Phase 2
Neoadjuvant Nivolumab Plus Ipilimumab in Resectable NSCLC (GALAXY 3)
Lung Cancer (Non-Small Cell)
The First Affiliated Hospital of Guangzhou Medical University69 enrolled1 locationNCT06926790
Recruiting
Phase 2
A Phase II Study of AK112 (PD1/VEGF Bispecific) in Combination with Chemotherapy in Patients with NSCLC
Lung Cancer (Non-Small Cell)
Sichuan University28 enrolled1 locationNCT06769295
Recruiting
Phase 1Phase 2
TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Lung Cancer
Lung CancerLung Cancer (Non-Small Cell)Lung Cancer Metastatic+1 more
Essen Biotech85 enrolled1 locationNCT06538012